Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_assertion description "[Currently, the most efficacious treatment for malignant gliomas is temozolomide; however, gliomas expressing the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) are resistant to this drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_assertion evidence source_evidence_literature NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_assertion SIO_000772 18089777 NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_assertion wasDerivedFrom befree-20150227 NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_assertion wasGeneratedBy ECO_0000203 NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP536713.RAB_SDat29RoSM1rJBFO41kIE0q9Q8j9g6s3oLMDX9zYE130_provenance.